Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2000.
Current Awareness.
Human Psychopharmacology: Clinical and Experimental,
Vol. 15,
Issue. 6,
p.
473.
Sokoloff, Pierre
Foll, Bernard Le
Perachon, Sylvie
Bordet, Regis
Ridray, Sophie
and
Schwartz, Jean-Charles
2001.
The dopamine D3 receptor and drug addiction.
Neurotoxicity Research,
Vol. 3,
Issue. 5,
p.
433.
Robarge, Michael J.
Husbands, Stephen M.
Kieltyka, Andrzej
Brodbeck, Robbin
Thurkauf, Andrew
and
Newman, Amy Hauck
2001.
Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3Receptor Subtype.
Journal of Medicinal Chemistry,
Vol. 44,
Issue. 19,
p.
3175.
Naranjo, Claudio A.
Tremblay, Lescia K.
and
Busto, Usoa E.
2001.
The role of the brain reward system in depression.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 25,
Issue. 4,
p.
781.
Reuter, M.
Netter, P.
Rogausch, A.
Sander, P.
Kaltschmidt, M.
Dörr, A.
and
Hennig, J.
2002.
The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects.
Human Psychopharmacology: Clinical and Experimental,
Vol. 17,
Issue. 5,
p.
213.
Maurice, Tangui
Martin-Fardon, Rémi
Romieu, Pascal
and
Matsumoto, Rae R
2002.
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity.
Neuroscience & Biobehavioral Reviews,
Vol. 26,
Issue. 4,
p.
499.
George, Tony P
Kosten, Therese A
and
Kosten, Thomas R
2002.
The potential of dopamine agonists in drug addiction.
Expert Opinion on Investigational Drugs,
Vol. 11,
Issue. 4,
p.
491.
Reuter, Martin
Netter, Petra
Toll, Claudia
and
Hennig, Juergen
2002.
Dopamine agonist and antagonist responders as related to types of nicotine craving and facets of extraversion.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 26,
Issue. 5,
p.
845.
Garcia‐Ladona, F. J.
and
Cox, B. F.
2003.
BP 897, a Selective Dopamine D3 Receptor Ligand with Therapeutic Potential for the Treatment of Cocaine‐Addiction.
CNS Drug Reviews,
Vol. 9,
Issue. 2,
p.
141.
Gál, Krisztina
and
Gyertyán, István
2003.
Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats.
Brain Research Bulletin,
Vol. 61,
Issue. 6,
p.
595.
Le Foll, Bernard
Diaz, Jorge
and
Sokoloff, Pierre
2003.
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
Synapse,
Vol. 47,
Issue. 3,
p.
176.
Le Foll, B
Schwartz, J-C
and
Sokoloff, P
2003.
Disruption of nicotine conditioning by dopamine D3 receptor ligands.
Molecular Psychiatry,
Vol. 8,
Issue. 2,
p.
225.
Cryan, John F.
Gasparini, Fabrizio
van Heeke, Gino
and
Markou, Athina
2003.
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
Drug Discovery Today,
Vol. 8,
Issue. 22,
p.
1025.
Gyertyán, István
and
Gál, Krisztina
2003.
Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
NeuroReport,
Vol. 14,
Issue. 1,
p.
93.
Newman, Amy Hauck
Cao, Jianjing
Bennett, Christina J
Robarge, Michael J
Freeman, Rebekah A
and
Luedtke, Robert R
2003.
N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists.
Bioorganic & Medicinal Chemistry Letters,
Vol. 13,
Issue. 13,
p.
2179.
Hackling, Anneke
Ghosh, Robin
Perachon, Sylvie
Mann, André
Höltje, Hans-Dieter
Wermuth, Camille G.
Schwartz, Jean-Charles
Sippl, Wolfgang
Sokoloff, Pierre
and
Stark, Holger
2003.
N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands.
Journal of Medicinal Chemistry,
Vol. 46,
Issue. 18,
p.
3883.
Brust, John C.M.
2004.
Neurological Aspects of Substance Abuse.
p.
139.
Francès, Henriette
Le Foll, Bernard
Diaz, Jorge
Smirnova, Maria
and
Sokoloff, Pierre
2004.
Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice.
NeuroReport,
Vol. 15,
Issue. 14,
p.
2245.
Aujla, Harinder
and
Beninger, Richard J.
2004.
Intra-BLA or Intra-NAc Infusions of the Dopamine D₃ Receptor Partial Agonist, BP 897, Block Intra-NAc Amphetamine Conditioned Activity..
Behavioral Neuroscience,
Vol. 118,
Issue. 6,
p.
1324.
Binder, Devin K.
2004.
Recent Advances in Epilepsy Research.
Vol. 548,
Issue. ,
p.
34.
Comments
No Comments have been published for this article.